Form 8-K K2M GROUP HOLDINGS, INC. For: Aug 06
http://archive.fast-edgar.com/20140806/AAZ9W22CZ22YN2Z2222L22ZZEBFGZZ8R6262
Filed on: August 6, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AL Sydbank A/S share buyback programme: transactions in week 44
- Efficacy Overtakes Novelty as Key Driver of Ingredient Value: Euromonitor International
- Atom Therapeutics to Present Phase 2b/3 Data Showing Superior Efficacy of Lingdolinurad (ABP-671), Compared to Febuxostat, for Patients with Chronic Gout and Hyperuricemia at ACR Convergence 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share